The syndrome of essential hypertension and suppressed plasma renin activity. Normalization of blood pressure with spironolactone.

Suppr

超能文献

作者信息

Carey R M, Douglas J G, Schweikert J R, Liddle G W

出版信息

Arch Intern Med. 1972 Dec;130(6):849-54.

PMID:5082464

Abstract

摘要

相似文献

The syndrome of essential hypertension and suppressed plasma renin activity. Normalization of blood pressure with spironolactone.

Arch Intern Med. 1972 Dec;130(6):849-54.

Spironolactone and hydrochlorothiazide in essential hypertension. Blood pressure response and plasma renin activity.

Arch Intern Med. 1972 Dec;130(6):855-8.

[Relations between hypotensive effect and modifications of volemia and plasma renin activity in patients with essential hypertension treated using spironolactone].

Minerva Med. 1977 Feb 18;68(8):509-14.

The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.

Circulation. 2007 Jul 17;116(3):268-75. doi: 10.1161/CIRCULATIONAHA.107.690396. Epub 2007 Jul 2.

Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.

Can Med Assoc J. 1983 Jan 1;128(1):31-4.

[Evaluation of the plasma renin activity and urinary aldosterone excretion in patients with essential hypertension treated with spironolactone. Note II].

Minerva Cardioangiol. 1976 May;24(5):352-9.

[Treatment of essential hypertension with spironolactone with reference to the plasma renin activity].

Wien Klin Wochenschr. 1973 Jun 8;85(23):413-7.

Prolonged alteration of renin responsiveness after spironolactone therapy. A cause of false-negative testing for low-renin hypertension.

N Engl J Med. 1974 Dec 5;291(23):1243-4. doi: 10.1056/NEJM197412052912309.

[Plasmatic renin activity in essential arterial hypertension. Hyporeninemic hypertension].

Rev Clin Esp. 1975 Apr 30;137(2):105-14.

Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?

Am J Hypertens. 2005 Dec;18(12 Pt 1):1631-5. doi: 10.1016/j.amjhyper.2005.06.010.

引用本文的文献

Enhanced detection of primary aldosteronism in hypertensive patients with obstructive sleep apnea using a novel diagnostic algorithm.

Endocrine. 2025 Jun 17. doi: 10.1007/s12020-025-04322-8.

ACE Inhibition to Distinguish Low-Renin Hypertension From Primary Aldosteronism.

Hypertension. 2025 Jun;82(6):1046-1055. doi: 10.1161/HYPERTENSIONAHA.125.24711. Epub 2025 Mar 31.

Shifting paradigms in primary aldosteronism: reconsideration of screening strategy via integrating pathophysiological insights.

Front Endocrinol (Lausanne). 2025 Jan 14;15:1372683. doi: 10.3389/fendo.2024.1372683. eCollection 2024.

Characterizing the Origins of Primary Aldosteronism.

Hypertension. 2025 Feb;82(2):306-318. doi: 10.1161/HYPERTENSIONAHA.124.24153. Epub 2024 Dec 11.

Prevalence and Characteristics of Low-renin Hypertension in a Primary Care Population.

J Endocr Soc. 2024 Jun 5;8(8):bvae113. doi: 10.1210/jendso/bvae113. eCollection 2024 Jul 1.

The Spectrum of Dysregulated Aldosterone Production: An International Human Physiology Study.

J Clin Endocrinol Metab. 2024 Aug 13;109(9):2220-2232. doi: 10.1210/clinem/dgae145.

Using Renin Activity to Guide Mineralocorticoid Receptor Antagonist Therapy in Patients with Low Renin and Hypertension.

Am J Hypertens. 2023 Jul 14;36(8):455-461. doi: 10.1093/ajh/hpad032.

Primary aldosteronism - a multidimensional syndrome.

Nat Rev Endocrinol. 2022 Nov;18(11):665-682. doi: 10.1038/s41574-022-00730-2. Epub 2022 Aug 31.

The Unrecognized Prevalence of Primary Aldosteronism.

Ann Intern Med. 2020 Oct 20;173(8):683. doi: 10.7326/L20-1097.

Evolution of the Primary Aldosteronism Syndrome: Updating the Approach.

J Clin Endocrinol Metab. 2020 Dec 1;105(12):3771-83. doi: 10.1210/clinem/dgaa606.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验